Search Results

71 - 80 of 147
Fact Sheet
En la actualidad, la terapia génica para la enfermedad de células falciformes se considera experimental y solo está a su disposición si participa en un estudio clínico.
Media Advisory
With the publication of 16 high-quality reference genomes from across vertebrates, the Vertebrate Genome Project establishes standards for biodiversity genomics and reports discoveries in comparative biology, conservation, and health research
… learn more about biodiversity, human health and disease. … The  Vertebrate Genomes Project , part of the  … to address fundamental questions in human biology and disease. These projects are in line with the larger goal of …
The Genomics Landscape
In the August 4, 2022 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., talks about the establishment of the Global Biodata Coalition (GBC), which aims to move towards more internationally coordinated, sustainable, and streamlined mechanisms that support the biodata ecosystem.
… resources are expected to expand in the future, with a disease-specific implementation study that builds upon the … Common Fund programs are trans-NIH (rather than being disease-specific or relevant to the mission of only one or a … for NIH grants that are not focused on Alzheimer’s Disease Intent to publish a funding opportunity announcement …
The Genomics Landscape
In the December 2, 2021 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., spotlights the re-opening of the Genome: Unlocking Life’s Code exhibition at the Smithsonian’s National Museum of Natural History (NMNH) in Washington, D.C.
… authors discuss published papers on topics such as human disease, genomic medicine, and genetic discrimination. In …
News Release
NIH researchers have developed and released an innovative software tool, called Verso, to assemble truly complete (i.e., gapless) genome sequences from a variety of species. The software makes the process of assembling complete genome sequences more affordable and accessible.
Fact Sheet
Pharmacogenomics is a growing area of genomic medicine that uses a patient's genomic information to help healthcare providers select the medications and dosages that are predicted to work best in each patient.
… what dosage is most appropriate and if a patient is at risk for an adverse reaction.   Pharmacogenomics is part of … be most effective for that patient while minimizing the risk of an adverse reaction. … Who may benefit from … genomic variant in the HLA-B  gene are at a higher risk for a severe allergic reaction to abacavir , which is …
The Genomics Landscape
In the December 8, 2022 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., looks back on the success of the Genome: Unlocking Life's Code exhibition as it came to a close in November.
… – covering “what’s in your genome,” “what’s your genetic risk,” “what’s in your microbiome,” and “what genomics might … would help researchers establish their role in health and disease. A new study describes the development of a … Harris – December 15 Genomics Videos GM1 gangliosidosis disease overview - Dr. Cynthia Tifft Irreducible subjects: …
News Release
NHGRI researchers have shown that areas of the genome related to brain development harbor variants that may account for behavioral differences among different dog lineages.
News Release
NHGRI has appointed Chris Gunter, Ph.D., as a senior advisor for genomics engagement. In this role, Dr. Gunter will advise the NHGRI director and the institute on issues and challenges associated with engaging the public about genomics and genomic medicine.
Tribute
A candid and kind genomics pioneer leaves a deep impact on NHGRI and the genomics community.
… Polymorphisms) and their connections to health and disease.     “I am saddened beyond words. Debbie, a beautiful … about those opportunities, and how we could take rare disease gene discovery to the next level.” Lisa Chadwick, …